Wednesday, 27 Jan 2021

China Biologic Products Inc. Q3 adjusted earnings Beat Estimates

Global Cord Blood Corporation Q2 Profit Climbs

Global Cord Blood Corporation (CO) released earnings for its second quarter that advanced from the same period last year.

The company’s bottom line came in at RMB131.43 million, or RMB1.08 per share. This compares with RMB120.35 million, or RMB0.99 per share, in last year’s second quarter.

The company’s revenue for the quarter fell 8.9% to RMB285.61 million from RMB313.46 million last year.

Global Cord Blood Corporation earnings at a glance:

-Earnings (Q2): RMB131.43 Mln. vs. RMB120.35 Mln. last year.
-EPS (Q2): RMB1.08 vs. RMB0.99 last year.
-Revenue (Q2): RMB285.61 Mln vs. RMB313.46 Mln last year.

Fresh Express Kit Caesar Supreme Recalled For E. Coli Concerns

Fresh Express is recalling expired Fresh Express Kit Caesar Supreme for potential contamination with Escherichia coli STEC 026 bacteria, according to the U.S. Food and Drug Administration.

The recall involves a limited number of cases of 10.5 oz. Fresh Express Kit Caesar Supreme with the Use-by Date of November 8, and Product Code S296. The recalled product was distributed primarily in Western and Southwestern U.S. states.

The product is now 9 days past the Use-By Date, but it may still be in stores or consumers’ homes.

According to the agency, a single randomly selected package of 10.5 oz. Fresh Express Kit Caesar Supreme yielded a positive result for E. coli STEC 026.

However, no illnesses are reported, and the company has not received any consumer complaints in association with this recall.

No other Fresh Express products are subject to recall.

E. coli STEC 026 can cause diarrhea, severe stomach cramps and vomiting. Most people recover within a week, but some illnesses can last longer and can be more severe.

Consumers who may still have the expired product at home in their refrigerators should discard and not consume it. Refunds are also available where purchased.

In similar incidents, Tanimura & Antle Inc. in early November has recalled its packaged single head romaine lettuce, citing possible contamination with E. Coli 0157:H7.

FCC affirms ZTE poses U.S. national security threat

WASHINGTON (Reuters) – The Federal Communications Commission (FCC) said on Tuesday it had rejected a petition from ZTE Corp asking the agency to reconsider its decision designating the Chinese company as a U.S. national security threat to communications networks.

The FCC announced in June it had formally designated Chinese’s Huawei Technologies Co and ZTE as threats, a declaration that bars U.S. firms from tapping an $8.3 billion government fund to purchase equipment from the companies.

The FCC on Dec. 10 will vote on rules to help carriers remove and replace untrusted equipment from networks.

Saudi cabinet approves renaming Saudi Arabian Monetary Agency to Saudi Central Bank – SPA

CAIRO (Reuters) – Saudi Arabia’s cabinet approved on Tuesday the renaming of the Saudi Arabian Monetary Agency to Saudi Central Bank, state news agency (SPA) reported.

White House approves intelligence brief for Biden

U.S. President Donald Trump arrives to speak to reporters in the Brady Press Briefing Room at the White House in Washington, U.S., November 24, 2020. REUTERS/Hannah McKay

WASHINGTON (Reuters) – The White House has given approval for President-elect Joe Biden to receive the President’s Daily Brief, the collection of classified intelligence reports prepared for the president, an administration official said on Tuesday.

The decision means Biden will have access to the latest intelligence about major national security threats around the globe.

Amazon And US Govt. To Act Jointly Against Counterfeit Goods

Online retail giant (AMZN) Tuesday announced a joint operation with the National Intellectual Property Rights Coordination Center (IPR Center) to stop counterfeit goods from entering the US.

The partnership will rely on intelligence gathered from Amazon’s Counterfeit Crimes Unit, logistics company DHL, and US Customs and Border Patrol (CBP).

“The IPR Center plays a critical role in securing the global supply-chain to protect the health and safety of the American public,” said IPR Center Director Steve Francis. “However, our efforts are increased with partners like Amazon to identify, interdict, and investigate individuals, companies, and criminal organizations engaging in the illegal importation of counterfeit products. This joint operation is our latest public-private initiative bringing us one step closer to border security.”

“Operation Fulfilled Action” relies on Amazon’s dominant positioning as both a distributor and marketplace for products.

The operation will analyze data and conduct targeted inspections aimed at preventing counterfeit products from entering the U.S. supply chain. The IPR Center and Amazon will leverage evidence obtained during the operation to expand on-going investigations, with the goal of holding bad actors accountable to the fullest extent of the law.

This operation will be led by Amazon’s Counterfeit Crimes Unit, which was created earlier this year to support law enforcement investigations and to initiate civil litigation against counterfeiters.

China Biologic Products Inc. Q3 adjusted earnings Beat Estimates

China Biologic Products Inc. (CBPO) revealed a profit for third quarter that fell from the same period last year.

The company’s earnings totaled $39.54 million, or $0.99 per share. This compares with $47.02 million, or $1.21 per share, in last year’s third quarter.

Excluding items, China Biologic Products Inc. reported adjusted earnings of $55.08 million or $1.39 per share for the period.

Analysts had expected the company to earn $1.28 per share, according to figures compiled by Thomson Reuters. Analysts’ estimates typically exclude special items.

The company’s revenue for the quarter rose 1.8% to $138.56 million from $136.11 million last year.

China Biologic Products Inc. earnings at a glance:

-Earnings (Q3): $55.08 Mln. vs. $54.43 Mln. last year.
-EPS (Q3): $1.39 vs. $1.40 last year.
-Analysts Estimate: $1.28
-Revenue (Q3): $138.56 Mln vs. $136.11 Mln last year.

Related Posts